Director Burke Richard T sold 11,500 shares in UnitedHealth Group Incorporated (NYSE:UNH) for $1,766,872 in transaction occurred on 2019/01/23. After making this transaction, the Director owns a direct stake of 3,082,000 shares, worth $466,000,000, as per the last closing price. On 2019/01/22 Ballard William C Jr, Director at UNH, dumped 5,000 shares at an average price of $266.61 per share. The selling total is valued at $19,156,977.

Separately, it had been reported that some other UNH insiders also took part of the insider trading activity. Director, Burke Richard T had divested 15,000 shares for $1,778,372 through a trade on 2019/01/17. Following this activity, the insider holds 3,908,250 shares worth $469,000,000 as of recent close. Wall Street’s most bullish UnitedHealth Group Incorporated (NYSE:UNH) analysts are predicting the share price to blow past $345 per share during the next 12 months. The current median share price forecast by them is $308, suggesting that the stock could increase 16.89% in that time frame. The average price target of $306.39 calls for a nearly 16.28% increase in the stock price.

UnitedHealth Group Incorporated (UNH) trading activity significantly improved as the volume at ready counter increased to 4,325,354 shares versus 3,750,565 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 3,880,666 shares. The share price rose 2.47% in recent trade and currently has a stock-market value of $260.37B. The shares finished at $263.5, after trading as low as $256.92 earlier in the session. It hit an intraday high Tuesday at $264. The stock is now 24.01% above against its bear-market low of $212.49 on March 23, 2018. It has retreated -9.28% since it’s 52-week high of $287.94 reached in December. Now the market price is up 19.25% on the year and up 5.77% YTD.

UNH’s 50 day simple moving average (SMA 50) price is $259.46 and its 200-day simple moving average (SMA 200) price is $257.67. The company’s stock currently has a total float of 956.38M shares. Its weekly volatility is hovering around 2.19% and felt 1.86% volatility in price over a month. On the upside, the share price will test short term resistance at around $266.03. On a downside, the stock is likely to find some support, which begins at $258.95. The failure to get near-term support could push it to $254.39.

It had seen a new analyst call from Stephens, which initiated the stock at Overweight on January 14. Analysts at Citigroup, shed their positive views on September 10 by lowering it fromBuy to Neutral. Analysts at SunTrust, made their first call about the stock on June 11, recommending it is Buy.

When looking at valuations, UnitedHealth Group Incorporated (UNH) has a pricey P/E of 21.62x as compared to industry average of 21.08x. Moreover, it trades for 15.86 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 5.07x price/book and 1.15x price/sales. Compared to others, UnitedHealth Group Incorporated is in a different league with regards to profitability, having net margins of 5.2%. To put some perspective around this, the industry’s average net margin is 4.87%. UNH’s ROE is 24.5%, which is also considerably better than the industry’s ROE of 19.84%.

Shares of UnitedHealth Group Incorporated (UNH) have gained 3.7% since the company’s last earnings report. Over the past 12 fiscal quarters, UnitedHealth Group Incorporated (NYSE:UNH) has topped consensus earnings estimates in 12 quarters (100%), missed earnings in 0 quarters (0%), whereas at 0 occasion EPS met analyst expectations. UNH last reported earnings on January 15, 2019 when it released Dec-18 results that exceeded expectations. The company raked in $3.28 per share, 47.09% change on the same period last year. That was better than consensus for $3.21. Revenue for the recent quarter stood at $58.42 billion, up 12% on last year and above the $58.01 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $59.17 billion to $60.23 billion, which should be compared with $59.15 billion generated last year. EPS is seen in a range of $3.5 to $3.63, against the $3.27 reported a year ago.